Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers

MLA

Ellen G. J. Hulskotte, et al. “Pharmacokinetic Interaction between the Hepatitis C Virus Protease Inhibitor Boceprevir and Cyclosporine and Tacrolimus in Healthy Volunteers.” Hepatology, vol. 56, Oct. 2012, pp. 1622–30. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c3a85c4068604a083ac08d31b3153c07&authtype=sso&custid=ns315887.

APA

Ellen G. J. Hulskotte, Edward O’Mara, Fengjuan Xuan, Marga G. J. A. van Zutven, Samir Gupta, Joan R. Butterton, Hwa-Ping Feng, & John A. Wagner. (2012). Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers. Hepatology, 56, 1622–1630.

Chicago

Ellen G. J. Hulskotte, Edward O’Mara, Fengjuan Xuan, Marga G. J. A. van Zutven, Samir Gupta, Joan R. Butterton, Hwa-Ping Feng, and John A. Wagner. 2012. “Pharmacokinetic Interaction between the Hepatitis C Virus Protease Inhibitor Boceprevir and Cyclosporine and Tacrolimus in Healthy Volunteers.” Hepatology 56 (October): 1622–30. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c3a85c4068604a083ac08d31b3153c07&authtype=sso&custid=ns315887.